NY-GENERAL-ATLANTIC
Kiwi.com , a leading online travel booking platform powered by cutting-edge technology, today announced a new Board of Directors to guide the Company through its next phase of growth.
Daniel Finnegan, former Chief Financial Officer and Chief Accounting Officer of Booking Holdings (formerly The Priceline Group Inc.), will serve as an independent Board Director. During Mr. Finnegan’s 14-year tenure with Booking Holdings, the company grew to about 22,000 employees and reached a valuation of more than $100 billion.
“I am excited for the opportunity to work with Oliver and the Kiwi team as they build towards ambitious goals that will ultimately provide extraordinary value and experiences to travelers worldwide,” said Daniel Finnegan.
Kiwi.com executives Oliver Dlouhý, Co-founder and CEO, and Juraj Striezenec, CFO, as well as General Atlantic Technology sector team members Tanzeen Syed, Managing Director, and Jessie Cai, Vice President, will also join the Board.
“I am grateful to be surrounded by a group of experts with whom I look forward to closely working as we scale Kiwi.com,” said Oliver Dlouhý. “Our new Board brings a diversity of strategic and operational experience spanning the technology and travel sectors, and Dan’s background as the former CFO of one of the world’s largest travel companies will be invaluable to our business. The creation of this team is an exciting milestone in this next chapter of our growth.”
In June 2019 Kiwi.com announced a strategic investment from General Atlantic , a leading global growth investor, to help scale the business and support management’s vision to create a seamless end-to-end travel experience for customers. General Atlantic has extensive experience in the global online travel industry, with current and past investments including Priceline, Airbnb, Meituan, Flixbus, Uber, Despegar.com, Smiles and Mafengwo.
Tanzeen Syed continued, “We believe the structure and expertise of this Board well-positions Kiwi.com to execute on its vision of creating a comprehensive travel experience for consumers around the globe. The addition of an independent Director of the caliber and experience level of Dan brings further momentum to the business as Kiwi.com enters this next phase of growth. General Atlantic is excited to be working alongside Oliver, the Board and the Kiwi.com team to continue building a next-generation travel technology platform.”
Kiwi.com, a rapidly growing technology company, was founded in 2012 and was recognized as the #1 fastest-growing Czech start-up by Forbes Magazine in 2017 and 2018. Through its proprietary technology and algorithms, Kiwi.com has a unique ability to offer expansive flight options to value-conscious consumers.
The Company pioneered technology that matches passengers to multiple carriers and flights on single itineraries and partners with airlines, online travel agencies, and metasearch engines to sell more than €1 billion in tickets across the globe.
About Kiwi.com
Kiwi.com was founded in 2012 by Oliver Dlouhý and Jozef Képesi. The travel tech company was created for travellers by travellers. Its proprietary algorithm, Virtual Interlining, allows users to combine flights from more than 750 carriers, including many that do not normally cooperate. Kiwi.com also provides its industry-leading Kiwi.com Guarantee, which protects customers from missed connections because of delay, schedule change or cancellation.
Kiwi.com powers more than 100 million flight searches every day and employs over 2,900 people worldwide. It is one of the fastest-growing technology companies in Central Europe. It entered the 2017 Deloitte Technology Fast 500 EMEA list in 7th place, becoming the highest ever ranked Czech company. For the second consecutive year, Kiwi.com was named best Start-up of the Czech Republic by Czech Forbes Magazine in July 2018.
2018 saw the launch of NOMAD, a revolutionary multi-city travel search tool, and Tequila, a B2B platform for partners of all sizes. Also in 2018, Kiwi.com incorporated ground transportation into its search technology.
About General Atlantic
General Atlantic is a leading global growth equity firm providing capital and strategic support for growth companies. Established in 1980, General Atlantic combines a collaborative global approach, sector specific expertise, a long-term investment horizon and a deep understanding of growth drivers to partner with great entrepreneurs and management teams to build exceptional businesses worldwide. General Atlantic has more than 150 investment professionals based in New York, Amsterdam, Beijing, Greenwich, Hong Kong, Jakarta, London, Mexico City, Mumbai, Munich, Palo Alto, São Paulo, Shanghai, and Singapore. For more information on General Atlantic, please visit the website: www.generalatlantic.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20190909005279/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 02:00:00 CET | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 00:34:00 CET | Press release
Announcement of Enry’s Island AdVentures: the world’s first video game to learn how to launch and scale startups, focused on democratizing innovation for “Long Tail Users” Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 21:37:00 CET | Press release
Part of the Digital Morocco 2030 strategy, 500 Global has been selected to support the Startup Venture Building (Startup VB) initiative. 500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to streng
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 17:00:00 CET | Press release
New capital accelerates Neural Concept’s ability to deliver transformative technologies and enterprise-wide AI impact across advanced industrial workflows.Platform delivers CAD-native, physics-aware AI and deep reasoning for engineering, saving customers $50 million annually, reducing late-stage redesigns by 30-50% and accelerating time to market by up to two years.The company has generated a fourfold increase in enterprise revenue over the past 18 months.More than 50 global companies are actively relying on the platform, including General Motors, General Electric Vernova, Leonardo Aerospace, Eaton, Safran, Renault Group and multiple Formula 1 teams. Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 16:57:00 CET | Press release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special?MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom